Donna Berry on Symptom Distress and Adherence
Donna L. Berry, from Dana-Farber Cancer Institute, on Symptom Distress and Oral Therapy Adherence.
Donna L. Berry, PhD, RN, AOCN, FAAN, Dana-Farber Cancer Institute, Director, The Phyllis F. Cantor Center for Nursing Research, Associate Professor of Medicine, Harvard Medical School, discusses a study that examined the relationship between symptom distress and adherence to oral chemotherapy or hormonal therapy that is taken at home.
The study enrolled 77 patients with a range of cancer diagnoses and found that as symptom distress increased, adherence decreased. Inversely, those reporting low symptom distress reported perfect adherence to therapy.
Berry notes that the findings from the study stress the importance of proper patient education and appropriate symptom management. Teaching a patient how to deal with the side effects of oral therapy may help improve adherence.
Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers
September 1st 2022In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.
